Immunotherapy drug gives non-small-cell lung cancer patients extra four months of life
Patients with advanced non-small-cell lung cancer survive four months longer with fewer side effects on an immunotherapy drug called atezolizumab compared to chemotherapy, according to a phase 3 clinical trial published in ...
Dec 13, 2016
0
2